It may be slightly less stable than GHK-Cu due to differences in copper binding affinity, which makes proper formulation and storage even more important
A reasonable candidate is someone who: Is already following a structured, clinician-supervised nutrition and activity plan Has a documented B12 deficiency or a condition that impairs B12 absorption Cannot tolerate GLP-1 medications, or is not a candidate for them Declines prescription pharmacotherapy and wants a non-stimulant, non-surgical adjunct Understands because the clinician has said so plainly that the injection is a supporting player A poor candidate is someone who wants the shot instead of the program
$80/50mg Thymosin Alpha-1 An immune-modulating peptide that enhances T-cell function and supports immune recovery
A 250 mcg dose requires 0.125 mL (12.5 units on a 100-unit insulin syringe)
Learn how your body responds, stabilize your dose, and establish a baseline before introducing AOD-9604
Some aggressive healing protocols run shorter, more intense cycles of 4 to 6 weeks at higher doses, followed by equivalent off-periods
